About Intrathecal Baclofen Therapy

Intrathecal baclofen therapy may reduce severe spasticity. The programmable pump delivers medication to where it’s needed – the spinal cord. This treatment option is adaptable, if necessary reversible, and non-destructive.

For spasticity of spinal origin, chronic infusion of baclofen via a drug delivery pump should be reserved for patients unresponsive to oral baclofen or those who experience intolerable side effects at effective doses.

What Is It?

Intrathecal baclofen therapy (ITB) therapy is a precise, targeted treatment that may reduce severe spasticity caused by multiple sclerosis.

Benefits and Risks

All treatment and outcome results are specific to the individual patient, and will form part of your consultation with your healthcare professional.

Please consult your healthcare professional for a full list of benefits, indications, precautions, clinical results, and other important medical information that pertains to ITB therapy.

Frequently Asked Questions

Review some common questions and concerns about how a baclofen pump (ITB therapy) may help minimise severe spasticity caused by multiple sclerosis.

Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.

Last updated: 27 Sep 2010

Section Navigation

Additional information

Health Tools

Contact Us

Medtronic Australasia Pty Ltd
97 Waterloo Road
North Ryde NSW 2113
PO Box 945
North Ryde NSW 1670
work 1800 668 670 (Toll Free)
work +61 (0)2 9857 9000